drugset / Trial / NCT02390986
An Extension Study of LON002 in Patients With Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to evaluate the long term safety and efficacy of LON002.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artemether | Small molecule | — | — |